{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-169818","form_type":"8-K","ticker":"LRMR","cik":"0001374690","company_name":"Larimar Therapeutics, Inc.","filed_at":"2025-07-31T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.839519+00:00","generated_at":"2026-05-17T22:13:52.224292+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Larimar Therapeutics prices $64.4M common stock offering at $3.20 per share","bullets":["Offering of 18,750,000 shares of common stock at $3.20; underwriters' over-allotment of 2,812,500 shares exercised in full.","Net proceeds expected approximately $64.4 million after underwriting discounts and expenses.","Joint book-running managers: Leerink Partners, Guggenheim Securities, Truist Securities, William Blair.","Offering expected to close July 31, 2025, subject to customary conditions."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-169818","json":"https://secwatch.observer/filing/0001193125-25-169818.json","markdown":"https://secwatch.observer/filing/0001193125-25-169818.md","text":"https://secwatch.observer/filing/0001193125-25-169818.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1374690/000119312525169818/0001193125-25-169818-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1374690/000119312525169818/d35960d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T22:13:52.224292+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}